MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Filter by vocabulary: issues (multisite):

As Indian prime minister Narendra Modi makes his first official visit to the US, MSF is urging the Indian government to resist US pressure to drop the use of public health safeguards in its intellectual property laws.

More >

 

On September 15, Gilead Sciences is expected to announce agreements with a handful of Indian pharmaceutical manufacturers to produce and sell generic versions of two new Hepatitis C drugs—sofosbuvir and ledipasvir. Approximately 180 million people live with Hepatitis C today, with 350,000 people dying annually of the disease.

More >

In a late-breaking, two-part special, FRONTLINE investigates two of the biggest stories out of Africa in recent months: the largest Ebola outbreak on record, and Nigeria’s fight against Boko Haram—the Islamist militant group that kidnapped nearly 300 schoolgirls in April. 

More >

NEW YORK, AUGUST 12, 2014  — The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today launched "The Reach of War," a multimedia documentary feature exploring a single day in the life of the ongoing conflict in Syria, through the perspective of medical workers, patients, and refugees.

More >

Phumeza Tisile, co-author of the DR-TB Manifesto and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide.

More >

 

Geneva/New York—Patent barriers and high prices on oral treatments for hepatitis C could make it too expensive for developing countries to scale-up diagnosis and treatment of the disease, said the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) today. The warning comes as the World Health Organization (WHO) issued the first-ever guidelines for treatment of hepatitis C virus (HCV). 

More >

Boston/New York, March 6, 2014—Two new studies released today by Epicentre,the research arm of the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) at CROI, the Conference on Retroviruses and Opportunistic Infections, point to reductions in new HIV infections in areas where HIV treatment has been greatly expanded. The studies are some of the first to look at large-scale antiretroviral therapy (ART) rollout in real-world high-HIV-burden settings in sub-Saharan Africa, and its possible impact on reducing new infections.

More >

Despite minimal concessions, US demands remain extremely dangerous to all patients’ health across the Asia-Pacific region.

More >

An anti-meningitis campaign in Benin delivers more than 150,000 doses with no losses from excess heat. View external media.

More >

JOHANNESBURG/NEWYORK, JANUARY 21, 2014—The international medical humanitarian organization Doctor Without Borders/Médecins Sans Frontières (MSF) is urging the South African government to continue to stand strong against a broad, multinational pharmaceutical industry effort to undermine and delay the efforts to reform patent laws and improve access to affordable medicines.

More >

Pages